Sophie Susen, PhD,MD

Professor of Haematology
Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France
Lille, Nord-Pas-de-Calais, France

Presentation(s):

• OC 14.1 - Perioperative management with efanesoctocog alfa in adults, adolescents, and children with severe hemophilia A in the phase 3 XTEND clinical program

  Sunday, June 23, 2024
  09:30 – 09:45 ICT

• PB0273 - von Willebrand factor pharmacokinetics model : real-life surgery data from the WILL-PK study

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0861 - Soluble ST2 is a Key outcome Biomarker in COVID-19: Insights from Discovery Randomized Trial

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• OC 50.1 - First interim analysis of clinical outcomes in adults and adolescents with severe hemophilia A receiving efanesoctocog alfa prophylaxis in XTEND-ed, a phase 3 long-term extension study

  Tuesday, June 25, 2024
  09:30 – 09:45 ICT

• PB1355 - Aortic endothelial cells response to pulsatile vs continuous flow at high shear stress

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• PB1329 - Place of the plasma mixing Bethesda assay to detect anti-ADAMTS13 antibodies for the diagnosis and follow-up of immune thrombotic thrombocytopenic purpura.

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• PB1376 - Plasminogen activator inhibitor- 1 (PAI-1) as an early marker of COVID-19 severity in patients with high fibrosis-4 index

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• OC 69.6 - Coagulopathy of trauma: Basics

  Tuesday, June 25, 2024
  14:45 – 16:00 ICT